Thomas Berger
Department of Neurology
University of Innsbruck
Austria
Name/email consistency: high
- Biomarkers in multiple sclerosis: role of antibodies. Berger, T., Reindl, M. Dis. Markers (2006)
- Multiple sclerosis. Berger, T. Autoimmunity (2004)
- Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F., Reindl, M. N. Engl. J. Med. (2003)
- Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis. Berger, T., Reindl, M. J. Neural Transm. Suppl. (2000)